Given the importance of Notch3 in the regulation of VSMC function, it is not surprising that abnormal Notch3 signalling has been implicated in cardiovascular diseases associated with excessive VSMCs proliferation and vascular remodelling, including pulmonary arterial hypertension (PAH). Here, NOTCH3 is linked to pulmonary arterial hypertension.